Stock Movers

On this episode of Stock Movers:
- Estee Lauder (EL) shares gain. The US beauty company and Spanish firm Puig confirmed talks about a potential business combination have ended. Analysts cite several reasons for the positive reaction to the termination of talks, including “aversion to large deals,” integration risk/potential dilution to shareholders, as well as distraction to core business and its Beauty Reimagined strategic plan. Some analysts see better M&A opportunities in fragrance, or in masstige/mass segments.
- Imax (IMAX) shares jump. The Wall Street Journal reported the large-screen theater company is exploring a sale and has approached entertainment companies as potential buyers. The sale process is in early stages and may not result in a deal, the report states, citing people familiar with the situation
- Denali Therapeutics (DNLI) shares slide. The drug developer said a mid-stage study of an experimental therapy for Parkinson’s disease, with partner Biogen, did not meet its primary or secondary endpoints.
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Estee Lauder (EL) share are climbing following collapse of a proposed combination with Puig Brands that would have created one of the world’s largest fragrance and skincare companies.
- IMAX Corp. (IMAX) shares jumped after the Wall Street Journal reported the large-screen theater company is exploring a sale and has approached entertainment companies as potential buyers.
- Ross Stores (ROST) shares are up after the off-price retailer boosted its comparable sales forecast for the full year. The firm also posted better-than-expected sales for the first quarter.
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- BJ's Wholesale (BJ) shares are moving after it reported adjusted earnings per share for the first quarter that beat the average analyst estimate.
- Tiger Brokers (TIGR) is sliding as China’s securities regulator plans to penalize Futu Holdings Ltd., UP Fintech Holding Ltd.’s Tiger Brokers and Longbridge Securities Ltd. for operating on the mainland without a license, marking a sharp escalation in a yearslong campaign against illicit cross-border brokerages.
- Estee Lauder (EL) share are climbing following collapse of a proposed combination with Puig Brands that would have created one of the world’s largest fragrance and skincare companies.
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.

On this episode of Stock Movers:

- Richemont gains 2.30% after the Cartier owner reported sales at constant exchange rates for the full year that beat the average analyst estimate. The Swiss luxury group’s earnings print is commended by analysts for its resiliency despite substantial Middle East exposure.
- Puig plunged on Friday following the collapse of a proposed combination with Estee Lauder Cos. that would have created one of the world’s largest fragrance and skincare companies.
- Julius Baer saw client inflows slow for the first four months of the year, with the bank’s continued de-risking efforts weighing on the Swiss wealth manager’s growth aspirations. A number of analysts described the numbers as “disappointing,” and shares were down as much as 9.25% in early trading in Zurich.
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Richemont gains 2.30% after the Cartier owner reported sales at constant exchange rates for the full year that beat the average analyst estimate. The Swiss luxury group’s earnings print is commended by analysts for its resiliency despite substantial Middle East exposure.
- Puig plunged on Friday following the collapse of a proposed combination with Estee Lauder Cos. that would have created one of the world’s largest fragrance and skincare companies.
- “Sector blues” are set to return for European chemicals, JPMorgan writes in a note downgrading Arkema, Evonik and IMCD to underweight, cutting Lanxess to neutral, and upgrading Clariant to overweight.
See omnystudio.com/listener for privacy information.